224 related articles for article (PubMed ID: 28521698)
1. Leishmanicidal and Trypanocidal Activity of Metal Complexes with 1,2,4-Triazolo[1,5-a]pyrimidines: Insights on their Therapeutic Potential against Leishmaniasis and Chagas Disease.
Salas JM; Caballero AB; Esteban-Parra GM; Méndez-Arriaga JM
Curr Med Chem; 2017; 24(25):2796-2806. PubMed ID: 28521698
[TBL] [Abstract][Full Text] [Related]
2. Lanthanide complexes containing 5-methyl-1,2,4-triazolo[1,5-a] pyrimidin-7(4H)-one and their therapeutic potential to fight leishmaniasis and Chagas disease.
Caballero AB; Rodríguez-Diéguez A; Salas JM; Sánchez-Moreno M; Marín C; Ramírez-Macías I; Santamaría-Díaz N; Gutiérrez-Sánchez R
J Inorg Biochem; 2014 Sep; 138():39-46. PubMed ID: 24861807
[TBL] [Abstract][Full Text] [Related]
3. Triazolopyrimidine compounds containing first-row transition metals and their activity against the neglected infectious Chagas disease and leishmaniasis.
Caballero AB; Rodríguez-Diéguez A; Quirós M; Salas JM; Huertas Ó; Ramírez-Macías I; Olmo F; Marín C; Chaves-Lemaur G; Gutierrez-Sánchez R; Sánchez-Moreno M
Eur J Med Chem; 2014 Oct; 85():526-34. PubMed ID: 25127147
[TBL] [Abstract][Full Text] [Related]
4. Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.
Benaim B; Garcia CR
Trop Biomed; 2011 Dec; 28(3):471-81. PubMed ID: 22433874
[TBL] [Abstract][Full Text] [Related]
5. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
6. A Practical Green Synthesis and Biological Evaluation of Benzimidazoles Against Two Neglected Tropical Diseases: Chagas and Leishmaniasis.
Bandyopadhyay D; Samano S; Villalobos-Rocha JC; Sanchez-Torres LE; Nogueda-Torres B; Rivera G; Banik BK
Curr Med Chem; 2017; 24(41):4714-4725. PubMed ID: 23317160
[TBL] [Abstract][Full Text] [Related]
7. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
Orosco D; Mendoza AR; Meléndez CM
Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
[TBL] [Abstract][Full Text] [Related]
9. Leishmanicidal and trypanocidal activities of Bolivian medicinal plants.
Fournet A; Barrios AA; Muñoz V
J Ethnopharmacol; 1994 Jan; 41(1-2):19-37. PubMed ID: 8170156
[TBL] [Abstract][Full Text] [Related]
10. Parasitology. Drugs to combat tropical protozoan parasites.
Gelb MH; Hol WG
Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
[No Abstract] [Full Text] [Related]
11. Exploring microalgal and cyanobacterial metabolites with antiprotozoal activity against Leishmania and Trypanosoma parasites.
Matos ÂP; Saldanha-Corrêa FMP; Gomes RDS; Hurtado GR
Acta Trop; 2024 Mar; 251():107116. PubMed ID: 38159713
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action.
Vieites M; Smircich P; Guggeri L; Marchán E; Gómez-Barrio A; Navarro M; Garat B; Gambino D
J Inorg Biochem; 2009 Oct; 103(10):1300-6. PubMed ID: 19361864
[TBL] [Abstract][Full Text] [Related]
13. Metal compounds for the treatment of parasitic diseases.
Fricker SP; Mosi RM; Cameron BR; Baird I; Zhu Y; Anastassov V; Cox J; Doyle PS; Hansell E; Lau G; Langille J; Olsen M; Qin L; Skerlj R; Wong RS; Santucci Z; McKerrow JH
J Inorg Biochem; 2008 Oct; 102(10):1839-45. PubMed ID: 18684510
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of leishmaniasis part III: synthesis and bioevaluation of novel aryl substituted terpenyl pyrimidines as antileishmanial agents.
Chandra N; Pandey S; Ramesh ; Suryawanshi SN; Gupta S
Eur J Med Chem; 2006 Jun; 41(6):779-85. PubMed ID: 16697490
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness.
Khare S; Nagle AS; Biggart A; Lai YH; Liang F; Davis LC; Barnes SW; Mathison CJ; Myburgh E; Gao MY; Gillespie JR; Liu X; Tan JL; Stinson M; Rivera IC; Ballard J; Yeh V; Groessl T; Federe G; Koh HX; Venable JD; Bursulaya B; Shapiro M; Mishra PK; Spraggon G; Brock A; Mottram JC; Buckner FS; Rao SP; Wen BG; Walker JR; Tuntland T; Molteni V; Glynne RJ; Supek F
Nature; 2016 Sep; 537(7619):229-233. PubMed ID: 27501246
[TBL] [Abstract][Full Text] [Related]
16. Innovative lead compounds and formulation strategies as newer kinetoplastid therapies.
Espuelas S; Plano D; Nguewa P; Font M; Palop JA; Irache JM; Sanmartín C
Curr Med Chem; 2012; 19(25):4259-88. PubMed ID: 22834813
[TBL] [Abstract][Full Text] [Related]
17. Novel selective inhibitor of Leishmania (Leishmania) amazonensis arginase.
da Silva ER; Boechat N; Pinheiro LC; Bastos MM; Costa CC; Bartholomeu JC; da Costa TH
Chem Biol Drug Des; 2015 Nov; 86(5):969-78. PubMed ID: 25845502
[TBL] [Abstract][Full Text] [Related]
18. Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis.
Marr JJ
J Lab Clin Med; 1991 Aug; 118(2):111-9. PubMed ID: 1906917
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antiparasital activity against Trypanosoma cruzi of three novel 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one-based complexes.
Caballero AB; Marín C; Rodríguez-Diéguez A; Ramírez-Macías I; Barea E; Sánchez-Moreno M; Salas JM
J Inorg Biochem; 2011 Jun; 105(6):770-6. PubMed ID: 21497152
[TBL] [Abstract][Full Text] [Related]
20. Diamidines as antitrypanosomal, antileishmanial and antimalarial agents.
Werbovetz K
Curr Opin Investig Drugs; 2006 Feb; 7(2):147-57. PubMed ID: 16499285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
